相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults
Brianna Kispal et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Comparison of adsorption of selected antibiotics on the filters in continuous renal replacement therapy circuits: in vitro studies
Dariusz Onichimowski et al.
JOURNAL OF ARTIFICIAL ORGANS (2020)
Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
Lei Zha et al.
ADVANCES IN THERAPY (2020)
Multidrug-resistant Klebsiella oxytoca ventriculitis, successfully treated with intraventricular tigecycline: A case report
Jose Luis Soto-Hernandez et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Pharmacokinetic/Pharmacodynamic Modeling of Seven Antimicrobials for Empiric Treatment of Adult Bloodstream Infections with Gram-Negative Bacteria in China
Cuicui Wang et al.
MICROBIAL DRUG RESISTANCE (2020)
High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
Patrick M. Honore et al.
ANNALS OF INTENSIVE CARE (2020)
A Retrospective Analysis of the Effect of Tigecycline on Coagulation Function
Bing Leng et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016
Fan Zhang et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Preliminary experience with tigecycline treatment for severe infection in children
Sheng Ye et al.
EUROPEAN JOURNAL OF PEDIATRICS (2018)
Efficacy and safety of tigecycline monotherapy versus combination therapy for the treatment of hospital-acquired pneumonia (HAP): a meta-analysis of cohort studies
Xiang-Rong Bai et al.
JOURNAL OF CHEMOTHERAPY (2018)
Nonlinear Protein Binding: Not What You Think
Amelia N. Deitchman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials
Yue Zhang et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2018)
Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report
Cheng Peng et al.
GUT PATHOGENS (2018)
Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae
Wentao Ni et al.
INFECTIOUS DISEASES (2018)
Tigecycline salvage therapy for critically ill children with multidrug-resistant/extensively drug-resistant infections after surgery
Ying Song et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies
Shupeng Lin et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
A. Broeker et al.
CRITICAL CARE (2018)
An update on the management of urinary tract infections in the era of antimicrobial resistance
Mazen S. Bader et al.
POSTGRADUATE MEDICINE (2017)
Use of tigecycline in pediatric clinical practice
Maria Vincenza Mastrolia et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding
Ravi Shankar Prasad Singh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
Jiawei Zeng et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii
Liverana Lauretti et al.
JOURNAL OF NEUROSURGERY (2017)
The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
Jian Wang et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections
Jiao Xie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Retrospective analysis of tigecycline shows that it may be an option for children with severe infections
Zheng-Yi Zhu et al.
ACTA PAEDIATRICA (2016)
Tigecycline: Alone or in combination?
Yun Cai et al.
INFECTIOUS DISEASES (2016)
Efficacy of Tigecycline for Secondary Acinetobacter Bacteremia and Factors Associated with Treatment Failure
Bo-Huang Liou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Tigecycline dosing is critical in preventing tigecycline resistance because relative resistance is, in part, concentration dependent
B. A. Cunha
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials
Matteo Bassetti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis
Derya Seyman et al.
INFECTIOUS DISEASES (2015)
Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia
Li Xu et al.
CHEMOTHERAPY (2015)
The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
Patrick M. Honore et al.
CRITICAL CARE (2015)
In vitro Susceptibility of Tigecycline against Multidrug-Resistant Gram-Negative Strains: Etest versus Agar Dilution
Sezen Ozkok et al.
CHEMOTHERAPY (2014)
Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation
Jiao Xie et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Serum and urine pharmacokinetics of tigecycline in obese class III and normal weight adults
Manjunath P. Pai
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline
K. Brust et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review
K. Brust et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Reassessment of Tigecycline Bone Concentrations in Volunteers Undergoing Elective Orthopedic Procedures
Indranil Bhattacharya et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Determination of Atypical Nonlinear Plasma-Protein-Binding Behavior of Tigecycline Using an In Vitro Microdialysis Technique
Jatinder Kaur Mukker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Tigecycline in the management of osteomyelitis: a case series from the bone and joint infection (BAJIO) database
Allen T. Griffin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials
Paul C. McGovern et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
Wentao Ni et al.
JOURNAL OF ANTIBIOTICS (2013)
2013 WSES guidelines for management of intra-abdominal infections
Massimo Sartelli et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2013)
Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia
Christopher M. Rubino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline
Sujata M. Bhavnani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Changes in MIC Within a Global Collection of Acinetobacter baumannii Collected as Part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009
Rayo Morfin-Otero et al.
CLINICAL THERAPEUTICS (2012)
Pharmacokinetics and Safety Profile of Tigecycline in Children Aged 8 to 11 Years With Selected Serious Infections: A Multicenter, Open-Label, Ascending-Dose Study
Jay Purdy et al.
CLINICAL THERAPEUTICS (2012)
Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis
Joan M. Korth-Bradley et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Antonio T. Freire et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections
Angelo Pan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis
E. Ediz Tutuncu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN THE ERA OF MULTI-DRUG RESISTANT BACTERIA
T. Herzog et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2010)
Pharmacodynamics of Tigecycline against Phenotypically Diverse Staphylococcus aureus Isolates in a Murine Thigh Model
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates
Anthony M. Nicasio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Matthew E. Falagas et al.
CURRENT DRUG METABOLISM (2009)
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Olaf Burkhardt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
Luigi Principe et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2009)
Tigecycline for treating bloodstream infections:: a critical analysis of the available evidence
Daniel Curcio et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
A review of tigecycline - the first glycylcycline
Lance R. Peterson
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Metabolism, excretion, and pharmacokinetics of [14C] tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects
Matthew Hoffmann et al.
DRUG METABOLISM AND DISPOSITION (2007)
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections
A. K. Meagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Keith A. Rodvold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of pooled clinical trial data
T Babinchak et al.
CLINICAL INFECTIOUS DISEASES (2005)
The pharmacokinetic and pharmacodynamic profile of tigecycline
AK Meagher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline
J Rello
JOURNAL OF CHEMOTHERAPY (2005)
Pharmacokinetic/pharmacodynamic profile for tigecycline - a new glycylcycline antimicrobial agent
AK Meagher et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
G Muralidharan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
分享论文
